Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3

schaue ich mir morgen mal genauer an, scheint vielversprechend zu sein danke für den tipp:)

Ich empfehle Bico, weiter nach vorne ;))

Seit fast vier Wochen ein schöner Anstieg.👍

4.37 prallen wir als ab da müssen wir durch

CELLINK, a global leader in 3D bioprinting technologies, is pleased to announce the signing of a distribution agreement with AXT, a prominent player within the scientific equipment landscape in Australia and the wider Oceania region. This strategic collaboration bolsters CELLINK’s growing presence in the region and represents another milestone in their ongoing expansion efforts. (July 25, Gothenburg) CELLINK, a global leader in 3D bioprinting technologies, is pleased to announce the signing of a distribution agreement with AXT, a prominent player within the scientific equipment landscape in Australia and the wider Oceania region. This strategic collaboration represents another milestone in CELLINK’s ongoing expansion efforts, and will bring their bioprinting technologies into more researchers’ hands in Australia and New Zealand. With this partnership, CELLINK aims to further enable researchers in Australia and New Zealand with cutting-edge bioprinting solutions, empowering them to advance their scientific endeavours and create the future of healthcare. By combining CELLINK’s state-of-the-art bioprinters and bioinks with ATX’s extensive distribution network and expertise, this collaboration promises to accelerate the adoption of bioprinting technologies across the region. “We are thrilled to partner with AXT and expand our collaborator network within region. Through this partnership we are confident we will continue to support the growing user base in the region,” said Tomoko Bylund, Head of Sales APAC, CELLINK. “AXT’s reputation for excellence, dedication to customer success and their strong presence in the Australian market make them an ideal partner for us. We believe this collaboration will not only benefit researchers in Australia but also contribute to the advancement of the entire bioprinting field.” AXT, known for its commitment to providing high-quality scientific equipment, is equally excited about the partnership. “We are honoured to be working with CELLINK, a truly innovative company at the forefront of bioprinting technologies,” said Richard Trett, CEO, AXT. “This collaboration enables us to offer our customers access to CELLINK’s impressive range of bioprinters and bioinks, allowing them to pursue ground-breaking research and drive significant advancements in the field of regenerative medicine.” The distribution agreement between CELLINK and AXT is expected to bolster CELLINK’s presence in the Oceania region and strengthen its position as a leading provider of bioprinting solutions worldwide. By combining CELLINK’s cutting-edge technology with AXT’s local expertise and support, researchers in Australia and New Zealand will be empowered to create ground-breaking tissue and organ models, facilitating discoveries that could revolutionize personalized medicine and patient care.

Jeder der in Bico investiert; ist ein Hit!

Ohne Scheiss ich liebe Euch alle

Geh einfach mal davon aus, dass ihr euch auskennt. Aktuell 170 Minus

Hab mir 100 Stück gekauft

Waaaaaaas???????

Sartourius 🚀 jetzt muss bico noch nachziehen 😊

ich glaub bico hat nicht vieles in Usa zu tun oder weill nach 15 30 passiert bei bico fast nie etwas

Denke schon q2 wird die Auswirkung nicht ganz so stark sein. Im Frühling letzten Jahres war corona schon kaum ein Thema mehr und die asiatische Konkurrenz war da schon da.

Das wird schon. Die kommenden Q2- und Q3-Zahlen werden sicherlich noch stark unter dem Vorjahresvergleichsumsätzen von Ginolis leiden, spätestens ab den Q4-Zahlen sollte es dann aber wieder besser aussehen. 🙂

EK 12 € 🙉 bin mal gespannt